We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Intl.Medical | INT | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.83 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.83 | 0.83 |
| Top Posts |
|---|
Posted at 15/7/2008 00:02 by ged5 jotoha1, thanks for your update. I presume the action is regarding Farsight. This scam seems to involve Sandford, Thomas and Acheson. All three have have been involved with three companies which have gone bust on the AIM market. AIM in my mind have neglected their responsibilities towards shareholders and should be held accountable. Please keep us updated on your actions and I will do likewise. Can anyone help in regards to the 4.7m shares that were sold between results and suspension. If anyone can relate any of the sales to anyone at INT or Shore Capital the information would be very much appreciated. |
Posted at 14/7/2008 20:25 by jotoha1 Pomp, will keep you informed as events unfold ,so far we are not including his time at INT , as we are unsure as to what his duties were with this company prior to leaving, will email you in the next couple of weeks. |
Posted at 08/7/2008 07:38 by cyberpost VGT were in similar problems as INT (VGT are loss making).. they also got suspended @0.54p for similar reasons. They've just been bought out by BATM at c.1.6p/share. RNS this morning. |
Posted at 29/5/2008 08:12 by dell314 Ged5 - thanks for yesterday's reply.Anyway, we have a £2mln working capital deficit in latest results and then a piece of ramptastic spiel from SCAP that totally ignores this fact turns everyone into a bull??? Doesn't the sum of New broker + Ramptastic broker note + £2mln net liabilities ring any alarm bells - not to mention the fact that INT apparently didn't want to put out results without the broker note? Doesn't this all sound like SCAP have been brought in to organise a fundraising? Rgds dell All IMHO, DYOR etc. |
Posted at 29/5/2008 05:51 by pomp circumstance Its a crying shame they werent able to procede with the corporate action.I intimated I thought this was their plan with the move to Shore and the comment from a director somewhile ago that they were so interested in million pund bolt-ons. From what i understand, the corporate action is not dead in the water. There is still a chance it might go thru at some point but their are a couple of issues that the other party need to resolve. From what i understand it would be immediately earnings enhancing and a good deal for both parties. As for cash, while cash balance are low, the business is cash generative and they have very good support from their bankers and shore capital, who were very supportive of the proposed corporate action. In the CEO we have a man of years of experience of building and integrating business and the chairman is very well connected. I dont see too many risks with INT, organic growth is slower bit looking good, and if thy can pull of a deal or two to enhance the size of the company, it will start to get more notice. I think Shore need to step up and bring in an extra institution or two who will mop up the overhang. Ive asked the question and it doesnt seem to be one party selling, but when the sales go thru they are often at below bid, so we are having the opportunity to buy into this exciting little company at rock bottom. I personally picked up another 300k yday at 1.25p, i expect them to be worth at leats 4p by the end of the year and more if the corporate action can be concluded. |
Posted at 27/5/2008 20:21 by martincoops Just my thoughts on what to expect tomorrow.Turnover of around $6.5 million A new product launch called Integrity a range of cardiology consumables that will include defibrillator pads, cuffs, lead wires, gels and pulse oximetry probes. Positive update on Surety needle with possible launch in other EU countries Further cost cutting savings coming through to bottom line increasing gross profit. Possible dividend payment. I know Ged disputed this last time I posted but they are looking at in this financial year so it could be here tomorrow. No sure if we will get any news on acquisition but they are always looking to add value so fingers crossed on that one. Oh and of course the latest brokers note. Well thats it, only a few hours to go before we find out. |
Posted at 23/5/2008 06:03 by martincoops Just for fun this was britishbulls advice yesterday eveningInternational Medical Devices PLC Daily Commentary Our system posted a BUY CONFIRMED today. The previous SELL recommendation was made on 03.03.2008 (80) days ago, when the stock price was 2.2300. Since then INT has fallen -35.87% . |
Posted at 22/5/2008 10:02 by ged5 Pomp,I think jotoha had a genuine grievance against Chris Thomas. He warned us of one company that failed under him and we had the announcement the other day about another company that looks like failing under him. I see it as a positive that he's parted company with INT. I hope the results tomorrow put an end to the constant fall of the share price As I said before I'm more interested in seeing sales in Surety and increased profitability. Any corporate action is a bonus. |
Posted at 19/3/2008 16:32 by rokkie soldi, lol, not a happy bunny then. INT have a great portfolio of products and it will be interesting to see the uptake of the Surety needle. AIM stocks are volatile but i think thats why people are interested in them, there is a greater risk/reward ratio.. |
Posted at 07/12/2007 07:25 by pomp circumstance good news!!! (or is it!!)7 December 2007 International Medical Devices plc ("IMD" or "the Company") Directors Remuneration and Convertible Loan Note International Medical Devices plc (AIM: INT), the medical supply company targeting the acute care, aged care, and devices markets, announces that its new CEO has agreed to take part of his remuneration in shares above the current market price, and that it has signed a convertible loan note. Bill McGrath joined the company as Chief Operating Officer on 2 November 2007, and became the Company's Chief Executive Officer on 3 December 2007. He has agreed to convert, in aggregate #70,000 of his remuneration into Ordinary Shares, at a price higher than today's market price, being 1,125,000 Ordinary Shares at 4p and 500,000 Ordinary Shares at 5p, being a total of 1,625,000 Ordinary Shares. The Company has also entered into a two year loan note with Trafalgar Capital Specialized Investment Fund amounting to #600,000 which carries conversion rights into Ordinary shares. IMD intends to utilise the funds in support of the Company's "buy and build" strategy, relating to potential acquisition opportunities. The provider has been issued 329,272 Ordinary Shares on entering into the agreement. Application has been made for the above 1,954,272 Ordinary Shares to be admitted to trading on AIM. It is expected that admission to trading on AIM will be effected and dealings in these new Ordinary Shares will commence on 13 December 2007. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
